Dexketoprofen Trometamol/Tramadol Hydrochloride

右酮洛芬氨丁三醇/盐酸曲马多

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDexketoprofen Trometamol/Tramadol Hydrochloride
Drug Alias Name盐酸曲马多/右酮洛芬氨丁三醇Tramadol/DexketoprofenTramadol Hydrochloride/Dexketoprofen TrometamolDexketoprofen/TramadolSkudexa
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor agonistsCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Mu opioid receptorCyclooxygenase-1
Therapy Area/IndicationsAcute PainPain
Global Approved IndicationsAcute Pain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date2016/02/01
Country/TerritoryCzechiaUkraineSlovakia +[15] 
CombinationsYes Tramadol HydrochlorideDexketoprofen Trometamol
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMenarini Group
China Registration ClassN/A

Develop Information

Active CompaniesMenarini Group
Inactive CompaniesN/A
Active IndicationsAcute Pain
Inactive IndicationsPain

Other Information

ATC CodeM01AE17M02AA27
Related LinksN/A